Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo

Hepatology

Volumn 47, Issue 2, 2008, Pages 473-483

  Shen, Bo ^a   Yu, Jun ^a,b   Wang, Shiyan ^a   Chu, Eagle S H ^a   Wong, V W S ^a   Zhou, Xin ^a   Lin, Ge ^a   Sung, Joseph J Y ^a   Chan, Henry L Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; ALANINE AMINOTRANSFERASE; CCAAT ENHANCER BINDING PROTEIN BETA; CHOLINE; CYTOCHROME P450 2E1; CYTOCHROME P450 4A; CYTOCHROME P450 4A10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPID PEROXIDE; METHIONINE; PHYLLANTHUS URINARIA EXTRACT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME RELEASE; FATTY ACID OXIDATION; FATTY LIVER; HEPATITIS; INFLAMMATION; LIPID STORAGE; LIVER CELL CULTURE; LIVER NECROSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHYLLANTHUS; PHYLLANTHUS URINARIA; PRIORITY JOURNAL;

ANIMALS; CAPSULES; CELLS, CULTURED; CHOLINE DEFICIENCY; FATTY LIVER; FLAVONOIDS; GLUCOSIDES; HEPATOCYTES; MALE; MEDICINE, HERBAL; METHIONINE; MICE; MICE, INBRED C57BL; PHYLLANTHUS; POLYSACCHARIDES; RATS; RATS, WISTAR;

EID: 39549108872     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22039     Document Type: Article

References (57)

1. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845.
2. Chan NN, Kong AP, Chan JC. Metabolic syndrome and type 2 diabetes: the Hong Kong perspective. Clin Biochem Rev 2005;26:51-57.
3. Lai SW, Tan CK, Ng KC. Epidemiology of fatty liver in a hospital-based study in Taiwan. South Med J 2002;95:1288-1292.
4. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. HEPATOLOGY 2006;43(2 Suppl 1):S99-S112.
5. Huang YL, Chen CC, Hsu FL, Chen CF. Tannins, flavonol sulfonates, and a norlignan from phyllanthus virgatus. J Nat Prod 1998;61:1194-1197.
6. Bagalkotkar G, Sagineedu SR, Saad MS, Stanslas J. Phytochemicals from Phyllanthus niruri Linn and their pharmacological properties. J Pharm Pharmacol 2006;58:1559-1570.
7. Chan HLY, Sung JJY, Fong WF, Chim AML, Yung PP, Hui AY, et al. Double-blinded placebo-controlled study on Phyllanthus urinaris for the treatment of chronic hepatitis B. Aliment Pharmacol Ther 2003;18:339-345.
8. Bhattacharjee R, Sil PC. The protein fraction of Phyllanthus niruri plays a protective role against acetaminophen induced hepatic disorder via its antioxidant properties. Phytother Res 2006;20:595-601.
9. Bhattacharjee R, Sil PC. Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties. Food Chem Toxicol. 2007;45:817-826.
10. Chatterjee M, Sarkar K, Sil PC. Herbal (Phyllanthus niruri) protein isolate protects liver from nimesulide induced oxidative stress. Pathophysiology 2006;13:95-102.
11. Kiemer AK, Hartung T, Huber C, Vollmar AM. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J Hepatol 2003;38:289-297.
12. Rao YK, Fang SH, Tzeng YM. Anti-inflammatory activities of constituents isolated from Phyllanthus polyphyllus. J Ethnopharmacol 2006;103:181-186.
13. Sailaja R, Setty OH. Protective effect of Phyllanthus fratetnus against allyl alcohol-induced oxidative stress in liver mitochondria. J Ethnopharmacol 2006;105:201-209.
14. Pramyothin P, Samosorn P, Pounqshompoo S, Chaichantipyuth C. The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury. J Ethnopharmacol 2006;107:361-364.
15. Parkes JG, Templeton DM. Modulation of stellate cell proliferation and gene expression by rat hepatocytes: effect of toxic iron overload. Toxicol Lett 2003;144: 225- 233.
16. Sahai A, Pan X, Paul R, Malladi P, Kohli R, Whitington PF. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and amino-transferase release by hepatocytes treared with methionine-choline-deficient medium. Am J Physiol Gastrointest Liver Physiol 2006;291:G55-G62.
17. Yu J, Ip E, Dela Pena A, Hou JY, Sesha J, Pera N, et al. COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. HEPATOLOGY 2006;43:826-836.
18. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999; 27: 612-616.
19. Ip E, Farrell G, Hall P, Kirsch R, Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. HEPATOLOGY 2003;38:123-132.
20. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-1075.
21. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989;38:1313-1319.
22. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
23. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996;111:1645-1653.
24. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. HEPATOLOGY 1998;27:128-133.
25. Wu D, Cederbaum AI. Ethanol and arachidonic acid produce toxicity in hepatocytes from pyrazole-treared rats with high levels of CYP2E1. Mol Cell Biochem 2000;204:157-167.
26. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis.II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001;281:G1135-G1139.
27. Abdel-Razzak Z, Garlatti M, Aggerbeck M, Barouki R. Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter. Biochem Pharmacol 2004;68:1371-1381.
28. Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, et al. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. HEPATOLOGY 2007;45:1108-1117.
29. Kelicen P, Tindberg N. Lipopolysaccharide induces CYP2E1 in astrocytes through MAP kinase kinase-3 and C/EBPbeta and -delta. J Biol Chem 2004;16;279(16):15734-15742. Epub 2003 Dec 11.
30. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. HEPATOLOGY 2003;38:413-419.
31. Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, Ohata K, et al. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 2006;26:39-45.
32. Koreish A, Mae Diehl A. Animal models of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:679-690.
33. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003;18:124-138.
34. Wong VW, Hui AY, Tsang SW, Chan JL, Tse AM, Chan KF, et al. Metabolic and adipokine profile of Chinese patients with non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006;4:1154-1161.
35. Sous Herruzo JA, Garcia Ruiz I, Perez Carreras M, Munoz Yague MT. Non-alcoholic fatty liver disease: from insulin resistance to mitochondrial dysfunction. Rev Esp Enferm Dig 2006;98:844-874.
36. Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. HEPATOLOGY 2003;38:999-1007.
37. Sanchez-Alcazar JA, Schneider E, Hernandez-Munoz I, Ruiz-Cabello J, Siles-Rivas E, de la Torre P, et al. Reactive oxygen species mediate the down-regulation of mitochondrial transcripts and proteins by tumour necrosis factor-alpha in L929 cells. Biochem J 2003;370:609-619.
38. Sanchez-Alcazar JA, Schneider E, Martinez MA, Carmona P, Hernandez-Munoz I, Siles E, et al. Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 2000;275:13353-13361.
39. Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998;17:2515-2524.
40. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003;278:13740-13746.
41. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003;52:2784-2789.
42. Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999;19:141-155.
43. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. HEPATOLOGY 2006;43:474-484.
44. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol 2002;161:155-161.
45. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336.
46. Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-198.
47. Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 2005;54:S73-S78.
48. Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemasters JJ, Brenner DA. Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes. FASEB J 2004;18:720-172.
49. Czaja MJ, Liu H, Wang Y. Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling. HEPATOLOGY 2003;37:1405-1413.
50. Schartenbetg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. HEPATOLOGY 2006;43:163-172.
51. Dela Pena A, Leclercq I, Field J, George J, Jones B, Farrell G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 2005;129:1663-1674.
52. Millward CA, Heaney JD, Sinasac DS, Chu EC, Bederman IR, Gilge DA, et al. Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta are protected against diet-induced obesity. Diabetes 2007;56:161-167.
53. Schroeder-Gloeckler JM, Rahman SM, Janssen RC, Qiao L, Shao J, Roper M, et al. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J Biol Chem 2007;282:15717-15729.
54. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistence. Proc Natl Acad Sci U S A 2006;103:10741-10746.
55. Rao MS, Reddy JK. PPARalpha in the pathogenesis of fatty liver disease. HEPATOLOGY 2004;40:783-786.
56. Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001;21:193-230.
57. Ip E, Farrell G, Hall P, Robertson G, Leclercq I. Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. HEPATOLOGY 2004;39:1286-1296.